MJN110’s Nesting Benefits Were Partial and Sex-Dependent in Mice
Improving a pain-depressed behavior does not necessarily restore that behavior completely. In a mouse study, repeated MJN110 produced partial relief of reduced nesting, with different persistence in males and females.
The drug acts on endocannabinoid breakdown
MJN110 inhibits monoacylglycerol lipase, an enzyme involved in breaking down 2-arachidonoylglycerol. It therefore alters endogenous cannabinoid signaling rather than administering THC itself. The study used dilute intraperitoneal lactic acid to depress nesting behavior.
The benefit did not persist equally
The supplied abstract reports significant but partial improvement on the first treatment day. After seven days, partial antinociception remained in males, while females developed tolerance. The investigators also measured cannabinoid-related G-protein function in spinal cord and several brain regions.
Functional assays add another layer
Repeated treatment produced modest reductions in maximum agonist-stimulated signaling, with regional and sex variation. These tissue findings are different from a direct chemical measurement of cannabis exposure. They also do not supply a clinical pain score.
The study is useful because it evaluates a behavior suppressed by a noxious stimulus, rather than relying only on reflex withdrawal. Nevertheless, nesting remains a mouse endpoint in a particular visceral-pain model. Sustained partial improvement in one group is not complete pain relief, and loss of benefit in another group should remain visible. Neither pattern can be converted into a claim about whether cannabis users are impaired or a recommendation to use an experimental enzyme inhibitor.
Related: interpreting cannabis tolerance claims.
Research cited
Diester CM; Balint H; Gillespie JC; Lichtman AH; Sim-Selley LJ; Selley DE; Negus SS. Effects of Repeated Treatment with the Monoacylglycerol Lipase Inhibitor MJN110 on Pain-Related Depression of Nesting and Cannabinoid 1 Receptor Function in Male and Female Mice. The Journal of pharmacology and experimental therapeutics (2024). doi:10.1124/jpet.123.001940. Findings discussed from the study abstract.
